Berapakah harga Novan, Inc. (NOVN)

Harga Novan, Inc. (NOVN) adalah $0.056

Apakah topi pasaran Novan, Inc. (NOVN)

Cap pasaran Novan, Inc. (NOVN) adalah $451.38K

Novan, Inc. (NOVN) Hasil Dividen

Novan, Inc. operates as a pre-commercial pharmaceutical entity specializing in nitric oxide-derived therapies for dermatological and anti-infective conditions. The company boasts a robust clinical-stage pipeline featuring several topical drug candidates. For skin-related ailments, these include SB204, a monotherapy aimed at acne vulgaris; SB206, an antiviral gel targeting viral skin infections; SB208, a broad-spectrum antifungal gel designed to combat various fungal skin and nail infections like athlete's foot; and SB414, a cream-based gel formulated for inflammatory skin diseases. Additionally, Novan is advancing SB207 to treat external genital warts, WH602 (an intravaginal gel) and WH504 (a non-gel formulation) both addressing high-risk human papillomavirus (HPV), and SB019, a candidate for SARS-CoV-2. The firm has cultivated strategic partnerships, holding a licensing agreement with Sato Pharmaceutical Co., Ltd., and engaging in a strategic alliance with Orion Corporation. Founded in 2006, Novan, Inc. maintains its headquarters in Durham, North Carolina.

Tahun	Hasil Dividen	Ubah
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Hasil Dividen

Ubah

Tidak cukup data untuk tarikh yang disediakan.

Syarikat	Hasil Dividen	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
Lonza Group AG LONN.SW	0.00%	CH
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	KR
UCB S.A. UCB.BR	0.65%	BE

Syarikat

Hasil Dividen

Negara